Gilead’s remdesivir gets US FDA approval for hospitalized Covid-19 patients
REUTERS, Oct 23 — The US Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with Covid-19,...